Grants for Small businesses - Federal

The Federal and State Technology (FAST) Partnership Program provides funding to organizations to execute state/regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards from women, socially/economically disadvantaged individuals, and small businesses in underrepresented areas - typically rural states.

This funding opportunity provides financial support for the development of affordable and culturally appropriate biomedical technologies aimed at reducing healthcare disparities among underserved populations in the United States.

The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL) announces an open competition for organizations interested in submitting applications for a project that supports the meaningful political and civic participation of youth in the Solomon Islands.

U.S. Embassy Mexico City of the U.S. Department of State announces an open competition for organizations to submit applications to carry out a program to promote workforce development in the printed circuit board (PCB) industry through curriculum development for PCB focused courses at secondary and tertiary educational levels, certificate programs, vocational instruction, dual education, technical English language skills building, and full or partial support for internships in Taiwanese PCB manufacturing firms either in Taiwan or Mexico.

This funding opportunity provides financial support to U.S.-based small businesses and academic researchers for the discovery and development of small molecule drugs targeting disorders of the nervous system.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and National Heart, Lung and Blood Institute (NHLBI), intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research communities. The Centers also provide outstanding environments for the training of new researchers capable of addressing high priority objectives in muscular dystrophy research. Center investigators are expected to participate in important community outreach efforts to increase awareness of their research activities among people with lived experience and the related advocacy communities and to incorporate community perspectives into the conduct of patient-centered research. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New and Renewal applications will be eligible. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

This grant provides funding to researchers and institutions to create expanded access programs for ALS patients who are ineligible for traditional clinical trials, allowing them to receive investigational treatments.

This funding opportunity supports research aimed at understanding how HIV-related changes in the immune system affect the risk of tuberculosis and hepatitis B in individuals undergoing treatment, encouraging innovative approaches and collaboration among diverse research teams.

This funding opportunity supports diverse organizations in conducting innovative research to better understand and address cardiovascular disease in individuals with type 1 diabetes.

This grant provides funding for collaborative projects between academic institutions and industry partners to develop and validate innovative technologies for disease diagnosis and treatment.

This funding opportunity provides financial support to a wide range of organizations, including state and local governments, nonprofits, and educational institutions, to implement evidence-based strategies for preventing and controlling parasitic infections across the United States.

This funding opportunity supports U.S. small businesses conducting innovative health-related research that requires clinical trials, fostering collaboration with research institutions to bring new technologies to market.

This funding opportunity supports early-career researchers who have recently completed their doctoral or clinical training, allowing them to launch independent research projects without the need for preliminary data.

This funding opportunity supports innovative research that utilizes existing HIV-related data and biospecimens to improve maternal and pediatric health outcomes.

This funding opportunity supports researchers in developing advanced human cell-based models of the nervous system to better understand its development, function, and aging, particularly in relation to neurological and age-related diseases.

This grant provides funding for researchers and organizations to develop and test innovative strategies to prevent and address the effects of prenatal alcohol exposure and Fetal Alcohol Spectrum Disorders.

This funding opportunity supports innovative research projects that explore new methods for identifying genetic causes of rare disorders, inviting a diverse range of applicants including governments, nonprofits, and businesses.

This funding opportunity supports collaborative research projects focused on advancing the understanding of autism spectrum disorders through multi-site partnerships among various research institutions and organizations.

This funding opportunity provides financial support to small businesses developing cancer-related technologies, helping them advance their projects toward commercialization by partnering with investors.

This funding opportunity supports research projects aimed at developing innovative interventions to reduce health disparities in liver diseases and liver cancer among underserved populations in the United States.